Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 31

1.

succinate

MedGen UID:
67427
Concept ID:
C0220918
Pharmacologic Substance
2.

Vitamin E

A natural fat-soluble antioxidant with potential chemopreventive activity. Also known as tocopherol, vitamin E ameliorates free-radical damage to biological membranes, protecting polyunsaturated fatty acids (PUFA) within membrane phospholipids and within circulating lipoproteins. Peroxyl radicals react 1000-fold faster with vitamin E than with PUFA. In the case of oxygen free radical-mediated tumorigenesis, vitamin E may be chemopreventive. (NCI04) [from NCI]

MedGen UID:
12116
Concept ID:
C0042874
Pharmacologic Substance
3.

Vitamins

NOTE: The "vitamin B, other" subclassification (VT109) includes combinations containing only vitamin B complex. Combinations containing only vitamin D are included in subclassification (VT509). Subclassification (VT709) includes combinations of vitamin K only. The "vitamins, other" subclassification (VT809) includes any product in which a vitamin is found in combination with an ingredient which is neither a vitamin nor a mineral. [from NDF-RT]

MedGen UID:
12117
Concept ID:
C0042890
Pharmacologic Substance
4.

alpha Tocopherol

A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture. [from MeSH]

MedGen UID:
197434
Concept ID:
C0969677
Pharmacologic Substance
5.

Malignant tumor of prostate

A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas. -- 2003 [from NCI]

MedGen UID:
138169
Concept ID:
C0376358
Neoplastic Process
6.

Malignant neoplastic disease

A general term for autonomous tissue growth exhibiting morphologic features of malignancy (e.g. severe atypia, nuclear pleomorphism, tumor cell necrosis, abnormal mitoses, tissue invasiveness) and for which the transformed cell type has not been specifically identified. [from NCI]

MedGen UID:
14297
Concept ID:
C0006826
Neoplastic Process
7.

Inflammation

A microscopic finding indicating the presence of acute, subacute or chronic inflammation in a tissue sample. [from NCI]

MedGen UID:
7072
Concept ID:
C0021368
Pathologic Function
8.

Carcinoma

type of cancer [from CHV]

MedGen UID:
2867
Concept ID:
C0007097
Neoplastic Process
9.

Rapidly involuting congenital hemangioma

MedGen UID:
698687
Concept ID:
C1275421
Congenital Abnormality
10.

Growth arrest

MedGen UID:
569472
Concept ID:
C0333951
Pathologic Function
11.

Prostate cancer

A cancer of the `prostate` (FMA:9600). [from HPO]

MedGen UID:
506673
Concept ID:
CN167851
Finding
12.

Nuclear Translocation

Nuclear Translocation is a subcellular process in which activated cytoplasmic proteins are transported into the cell nucleus as part of a signal transduction pathway to modify cell function (typically gene expression) in response to a signaling event or condition. [from NCI]

MedGen UID:
273609
Concept ID:
C1518440
Molecular Function
13.

Error occurred: cannot get document summary

ID:
272128

14.

Carcinoma of prostate

One of the most common malignant tumors afflicting men. The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes. Adenocarcinomas represent the overwhelming majority of prostatic carcinomas. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. -- 2002 [from NCI]

MedGen UID:
108657
Concept ID:
C0600139
Neoplastic Process
15.

Examined for

Having been subjected to inspection or evaluation. [from NCI]

MedGen UID:
83047
Concept ID:
C0332128
Finding
16.

Tocopherols

group of lipoid antioxidants composed of a bicyclic benzo-gamma- pyran ring system with one or more long aliphatic side chains; dietary requirement of rodents and other animals (but not humans) for normal reproduction, circulation, and muscle and other functions. [from CRISP]

MedGen UID:
39545
Concept ID:
C0087096
Pharmacologic Substance
17.

Inhibition

MedGen UID:
5809
Concept ID:
C0021469
Molecular Function
18.

Neoplastic Cell Transformation

A pathologic process that involves the transformation of normal cells to a neoplastic state and resulting in polyclonal or monoclonal neoplastic cell proliferation. [from NCI]

MedGen UID:
3302
Concept ID:
C0007621
Neoplastic Process
19.

Male Urogenital Diseases

Pathological processes of the male URINARY TRACT and the reproductive system (GENITALIA, MALE). [from MeSH]

MedGen UID:
318601
Concept ID:
C1720894
Disease or Syndrome
20.

Molecular Mechanisms of Pharmacological Action

Pharmacological activities at the molecular level of DRUGS and other exogenous compounds that are used to treat DISEASES and affect normal BIOCHEMISTRY. [from MeSH]

MedGen UID:
226255
Concept ID:
C1258062
Molecular Function

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...